What is the treatment for Group B streptococcal (strep B) infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Group B Streptococcus (Strep B) Infections

Penicillin G is the treatment of choice for Group B streptococcal infections due to its proven efficacy, safety, narrow spectrum, and low cost. 1

First-Line Treatment Options

  • Penicillin G is the first-line treatment for invasive Group B streptococcal (GBS) infections in adults, with a recommended dosage of 12-20 million units/day divided every 4-6 hours for 2-4 weeks, depending on the type of infection 1
  • Ampicillin is an acceptable alternative to penicillin G, particularly in young children due to better taste acceptance 1
  • For severe infections such as sepsis, penicillin or ampicillin should be combined with gentamicin for synergistic effect 1, 2

Treatment for Penicillin-Allergic Patients

  • For patients with non-severe penicillin allergy (no history of anaphylaxis), first-generation cephalosporins like cefazolin are appropriate alternatives 3, 4
  • For patients with severe penicillin allergy (high risk of anaphylaxis), clindamycin is recommended if the GBS isolate is susceptible to this antibiotic 1, 3
  • If GBS isolate susceptibility is unknown or shows resistance to clindamycin, vancomycin should be used in penicillin-allergic patients 1, 3
  • Important: Approximately 20% of GBS isolates are resistant to clindamycin, so susceptibility testing should always be performed before using this antibiotic 5

Treatment by Infection Type

Invasive GBS Infections in Adults

  • For bacteremia and soft tissue infections: Penicillin G 12-20 million units/day IV divided every 4-6 hours 1, 6
  • For endocarditis: Penicillin G for 4 weeks, often combined with gentamicin 1
  • For osteomyelitis, pneumonia, and other serious infections: High-dose penicillin G with surgical management when appropriate (particularly for soft-tissue or bone infections) 6

Neonatal GBS Infections

  • For suspected or confirmed neonatal sepsis: Combination of ampicillin (100-200 mg/kg/day divided in 4-6 doses) and gentamicin (3 mg/kg/day) 1
  • For meningitis: Treatment duration of 14-21 days 1
  • All newborns with signs of sepsis should undergo a full diagnostic evaluation (including lumbar puncture) and receive empirical antimicrobial therapy immediately 5

Intrapartum Antibiotic Prophylaxis (IAP)

  • For GBS-positive pregnant women: Penicillin G IV with initial dose of 5 million units, followed by 2.5-3 million units every 4 hours until delivery 1, 3
  • Alternative for IAP: Ampicillin 2g IV initial dose, followed by 1g every 4 hours until delivery 1
  • For penicillin-allergic pregnant women not at high risk for anaphylaxis: Cefazolin 2g IV initial dose, then 1g IV every 8 hours until delivery 3
  • Adequate IAP is defined as ≥4 hours of penicillin, ampicillin, or cefazolin before delivery 5, 3

Duration of Treatment

  • For invasive infections: 2-4 weeks depending on infection site and severity 1
  • For endocarditis: 4 weeks of therapy 1
  • For meningitis: 14-21 days 1
  • For intrapartum prophylaxis: Continue until delivery 3

Important Clinical Considerations

  • Intramuscular benzathine penicillin G (Bicillin L-A) alone is insufficient for eradicating GBS colonization in pregnant women but may be useful as adjunctive treatment for patients at risk for rapid delivery 7
  • The incidence of resistance to non-beta-lactam antibiotics (clindamycin, erythromycin, and fluoroquinolones) has increased, making susceptibility testing crucial 8
  • Penicillin G remains effective against GBS, with only rare isolates showing reduced susceptibility 8

By following these evidence-based treatment recommendations, clinicians can effectively manage Group B streptococcal infections while minimizing morbidity and mortality in affected patients.

References

Guideline

Tratamiento para el Estreptococo Beta (Grupo B)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Babies Born to GBS Positive Mothers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Efficacy of intramuscular penicillin in the eradication of group B streptococcal colonization at delivery.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2005

Research

Group B Streptococcus (Streptococcus agalactiae).

Microbiology spectrum, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.